New Publication Explores Polypodium Leucotomos as Afamelanotide Adjunct in EPP

A new publication related to afamelanotide has appeared in the scientific literature as of September 1, 2026. Titled "Adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria: An exploratory study," it was published in the journal Photochemistry and photobiology. The publication is described as an exploratory study examining the adjunctive use of Polypodium leucotomos extract in patients with erythropoietic protoporphyria, a condition associated with afamelanotide use. No specific findings, results, or outcome data were provided in the available event information. The publication record does not include details on study design, patient numbers, or conclusions beyond the title and journal listing. Readers interested in the full findings should consult the original publication directly through the provided source link. This brief reports only the existence and bibliographic details of the publication as recorded. For more background on afamelanotide, including its approved regulatory status and general context, readers can refer to the compound overview.